TEL AVIV, Israel , Nov. 18, 2025 /PRNewswire/ -- RADCOM Ltd. (Nasdaq: RDCM) announced today that it has secured a contract for its Smart Network Visibility Solution through Rakuten Symphony for a leading mobile operator.

image for news RADCOM Secures Contract for Smart Network Visibility Solution through Rakuten Symphony

REHOVOT, Israel , Nov. 18, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical aesthetics, today announced that it will report financial results for the third quarter of 2025 on Wednesday, November 26, 2025, before the opening of the U.S. financial markets. About CollPlant CollPlant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on 3D bioprinting of tissues and organs, tissue repair and medical aesthetics.

image for news COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS

Protiviti is honored by Microsoft for outstanding achievement and innovation MENLO PARK, Calif. , Nov. 18, 2025 /PRNewswire/ -- Global consulting firm Protiviti has been selected for the AI Business Solution's 2025-2026 Microsoft Inner Circle.

image for news Protiviti Receives 2025-2026 Microsoft AI Business Solutions Inner Circle Award

Strengthens Intellectual Property Portfolio and Provides Protection for Therapeutic Combination in Acclaim-3 Clinical Trial AUSTIN, Texas , Nov. 18, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX ), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the United States Patent and Trademark Office (USPTO) has granted Genprex a patent that covers the use of the Company's lead drug candidate, Reqorsa® Gene Therapy, in combination with PD-L1 antibodies, such as Tecentriq®, through 2037. "We continue to build protection around our lead drug candidate, REQORSA, and this new …

image for news Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers

More Than Half Plan to Expand Their Businesses, While Many Remain Worried About Inflation, Interest Rates, Supply Chains and Healthcare Costs CHARLOTTE, N.C. , Nov. 18, 2025 /PRNewswire/ -- Small and mid-sized business owners are cautiously optimistic about the coming year, with 74% expecting revenue increases and nearly 60% planning to expand their businesses, according to the 2025 Bank of America Business Owner Report, conducted in partnership with the Bank of America Institute.

image for news BofA Report: 74% of Small and Mid-Sized Business Owners Expect Revenue to Increase in the Next Year

LOS ANGELES , Nov. 18, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announced that the Company will be featured in a key opinion leader (KOL) webinar, "Redefining SoC in Complicated Staph. aureus Bacteremia to Unlock a Real Opportunity" on November 25 th, 2025 at 10:00am EST.

image for news Armata Pharmaceuticals Announces Key Opinion Leader Webinar on S. aureus Bacteremia and AP-SA02 Hosted by Jones Research on November 25th at 10:00am EST

MONTRÉAL, Nov. 18, 2025 /PRNewswire/ - BCE Inc. (TSX: BCE) (NYSE: BCE) today announced that none of its fixed rate Cumulative Redeemable First Preferred Shares, Series R (Series R Preferred Shares) will be converted into floating rate Cumulative Redeemable First Preferred Shares, Series Q (Series Q Preferred Shares) on December 1, 2025. On October 17, 2025, BCE notified holders of Series R Preferred Shares that they could elect to convert their shares into Series Q Preferred Shares subject to the terms and conditions attached to those shares.

image for news BCE reports results of conversion of its series R preferred shares into series Q preferred shares

Main Street Announces New Portfolio Investment — Neutral

MAIN   PRNewsWire — November 18, 2025

Invests $47.0 Million in Recapitalization of a Franchisee of Swim Schools HOUSTON , Nov. 18, 2025 /PRNewswire/ -- Main Street Capital Corporation (NYSE: MAIN) ("Main Street") is pleased to announce that it recently completed a new portfolio investment totaling $47.0 million to facilitate the minority recapitalization of a leading swim school franchisee (the "Company"). Main Street partnered with the Company's existing owners and management team to facilitate the transaction, with Main Street's investment including a combination of first lien, senior secured term debt and a direct minority equity investment.

image for news Main Street Announces New Portfolio Investment

CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / November 18, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conference: Piper Sandler's 37th Annual Healthcare Conference, on Tuesday, December 2nd at 11:00am ET A live webcast of each of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website. investors.modernatx.com.

image for news Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025

LAVAL, QC / ACCESS Newswire / November 18, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Jean-Jacques Charhon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference in Coral Gables, Florida on December 2, 2025. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website.

image for news Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference

MORRISVILLE, N.C.--(BUSINESS WIRE)-- #JefferiesHealthcare--Presentation will focus on its flagship MRD assay, Pathlight, accompanied by a commercial update following its favorable Medicare coverage.

image for news Saga Diagnostics to Present at Jefferies Global Healthcare Conference in London

HEINZ Debuts First-Ever Gravy Condiment Exclusively for Thanksgiving Leftovers — Neutral

KHC   Business Wire — November 18, 2025

PITTSBURGH & CHICAGO--(BUSINESS WIRE)--This Thanksgiving, HEINZ, the global leader in condiments and market leader of US gravy,1 is turning its attention to the day after Thanksgiving with the debut of HEINZ Leftover Gravy. The first-ever squeezable bottle of HEINZ Homestyle Turkey Gravy transforms the Thanksgiving staple into a condiment perfectly poised for the ultimate leftover sandwich. Thanksgiving has evolved into more than just one meal — it's a multiday celebration. 94 percent of Americ.

image for news HEINZ Debuts First-Ever Gravy Condiment Exclusively for Thanksgiving Leftovers

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has expanded its Spectrum Therapeutics portfolio in Australia with the availability of new softgel capsules, further enhancing the Company's medical cannabis offerings in the region. The formats include Spectrum Yellow Cannabis Oil Softgels (CBD 20mg), Spectrum Red Cannabis.

image for news Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels

SAN MATEO, Calif.--(BUSINESS WIRE)--Roblox Corporation (NYSE: RBLX), an immersive gaming and creation platform, today announced it is in the process of rolling out age-based chat, following its announcement in September. Roblox will be the first online gaming or communication platform to require age checks for communication, which the company hopes sets a new industry standard. Age-based chat is designed to limit conversations to users with similar ages, as appropriate. All users can now volunt.

image for news Roblox Expands Facial Age Checks for Communication, Setting New Safety Standard

Ziff Davis to Participate in Two Investor Conferences in December — Neutral

ZD   Business Wire — November 18, 2025

NEW YORK--(BUSINESS WIRE)--Ziff Davis, Inc. (NASDAQ: ZD), today announced its participation in two investor conferences in December. Details of the conferences are as follows: UBS Global Technology and AI Conference Location: The Phoenician, Scottsdale, AZ Date and time: December 3, 2025, 7:35 am (MT) Webcast: https://cc.webcasts.com/ubsx001/120125a_js/?entity=77_84H38W5 Barclays Global Technology Conference Location: The Palace Hotel, San Francisco, CA Date and time: December 10, 2025 Webcast:.

image for news Ziff Davis to Participate in Two Investor Conferences in December

Klarna Powers Fair Financing Hypergrowth with $6.5bn US Agreement — Neutral

KLAR   Business Wire — November 18, 2025

NEW YORK--(BUSINESS WIRE)--Klarna, the global digital bank and flexible payments provider, announced today that investment funds managed by Elliott Investment Management, a U.S.-based investment firm, will purchase Klarna's U.S. Fair Financing loans, supporting the continued expansion of this product in the United States. The companies expect to facilitate a total of $6.5bn-worth of loans over the two-year term of the agreement. The agreement enables Klarna to sell part of its existing Fair Fin.

image for news Klarna Powers Fair Financing Hypergrowth with $6.5bn US Agreement

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vyome Holdings Third Quarter 2025 Earnings Release.

image for news Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing

AECOM reports fourth quarter and full year fiscal 2025 results — Neutral

ACM   Business Wire — November 18, 2025

DALLAS--(BUSINESS WIRE)--AECOM (NYSE:ACM), the trusted global infrastructure leader, today reported fourth quarter and full year fiscal 2025 results. Fourth Quarter Fiscal 2025 Full Year Fiscal 2025 (from Continuing Operations; $ in millions, except EPS) As Reported YoY % Change Adjusted1 (Non-GAAP) YoY % Change As Reported YoY % Change Adjusted1 (Non-GAAP) YoY % Change Revenue $4,175 2% -- -- $16,140 0% -- -- Net Service Revenue (NSR)2 -- -- $1,967 8% -- -- $7,573 6% Operating.

image for news AECOM reports fourth quarter and full year fiscal 2025 results

Fall 2025 Snapshot Of Expected Future S&P 500 Earnings — Positive

IVV  SPLG  SPXL  SPY  SSO  UPRO  VOO   Seeking Alpha — November 18, 2025

Every three months, we take a snapshot of the expectations for future earnings in the S&P 500 (SPX) at approximately the midpoint of the current quarter. The current projection for the S&P 500's earnings per share through the end of 2025 is $244.51, which would represent a 16.3% year-over-year gain over December 2024's finalized earnings of $210.17. Looking further forward through the end of 2026, Standard & Poor's projects the S&P 500's earnings will be $281.78 per share.

image for news Fall 2025 Snapshot Of Expected Future S&P 500 Earnings

QUANTA SERVICES ANNOUNCES QUARTERLY CASH DIVIDEND — Neutral

PWR   PRNewsWire — November 18, 2025

HOUSTON , Nov. 18, 2025 /PRNewswire/ -- Quanta Services, Inc. (NYSE: PWR) announced today that its Board of Directors has declared a quarterly cash dividend to stockholders of $0.11 per share, or a rate of $0.44 per share on an annualized basis, which represents an approximately 10.0% increase from Quanta's last quarterly cash dividend paid in October 2025. The dividend is payable on January 12, 2026, to stockholders of record as of January 2, 2026.

image for news QUANTA SERVICES ANNOUNCES QUARTERLY CASH DIVIDEND